Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Tendinopathy: full-pipeline trial registry

5 of 11 indexed Tendinopathy trials are currently recruiting.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 5 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Tendinopathy: 11 US clinical trials tracked, 5 recruiting.

Tendinopathy is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Emory University, running 2 of these trials.

Enrollment posture brief

Registry condition tendinopathy

OPEN 5 | RECR 45% | LATE 2 | EARLY 2 | RANK #1577 | SPON 2

Nearest open-share peer: Advanced Breast Carcinoma (45% recruiting · 11 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Tendinopathy (this)45%Acquired Brain Injury36.4%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Tendinopathy

Tendinopathy lists 5 open slots (45% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Tendinopathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Tendinopathy recruits in line with its size-band peers.

    5 of 11 indexed trials (45.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Tendinopathy research.

    Emory University accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Most Tendinopathy trials plan to enrol fewer than 100 people.

    Median target enrolment is 45 among the 11 trials that report a genuine target (sentinel values excluded). 8 of those (72.7%) plan for fewer than 100 participants.

  4. Tendinopathy research is mostly interventional.

    9 interventional and 2 observational studies make up this index (81.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 42

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 4 2

Named interventions

Most-linked intervention names on Tendinopathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Rotation Medical Bioinductive Implant Device
1 trials
Platelet Rich Plasma plus IGF Device
1 trials
Orthoses and Exercise Procedure
1 trials
SAM Ultrasound Diathermy Device Device
1 trials
PRP Biological
1 trials
CTM Boost Biological
1 trials
Embolization Device
1 trials
Platelet Rich Plasma Preparation Device
1 trials

US sites by state

Facility locations filed on Tendinopathy trials. A trial with sites in several states counts in each.

Pennsylvania 3 trials
Georgia 2 trials
Utah 1 trials
Texas 1 trials
Ohio 1 trials
Minnesota 1 trials
Maryland 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Tendinopathy page

11 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tendinopathy condition card totals 11 registered trials; most-linked intervention Rotation Medical Bioinductive Implant; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.